Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

Article  PubMed  Google Scholar 

Wang BR, Chen YA, Kao WH, Lai CH, Lin H, Hsieh JT. Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. Biomedicines. 2022;10:1872.

Borno H, George DJ, Schnipper LE, Cavalli F, Cerny T, Gillessen S. All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book. 2019;39:302–8.

Article  PubMed  Google Scholar 

Moyer VA, USPST Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120–34.

Article  PubMed  Google Scholar 

Qiao EM, Lynch JA, Lee KM, Kotha NV, Nalawade V, Voora RS, et al. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. J Natl Cancer Inst. 2022;114:592–9.

Article  PubMed  Google Scholar 

Vietri MT, D’Elia G, Caliendo G, Resse M, Casamassimi A, Passariello L, et al. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention. Int J Mol Sci. 2021;22:3753.

Kakarla M, ChallaSivaKanaka S, Hayward SW, Franco OE. Race as a Contributor to Stromal Modulation of Tumor Progression. Cancers (Basel). 2021;13:2656.

Christofori G. New signals from the invasive front. Nature 2006;441:444–50.

Article  CAS  PubMed  Google Scholar 

Bhardwaj A, Srivastava SK, Khan MA, Prajapati VK, Singh S, Carter JE, et al. Racial disparities in prostate cancer: a molecular perspective. Front Biosci (Landmark Ed). 2017;22:772–82.

Article  CAS  PubMed  Google Scholar 

Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, et al. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer. 2006;5:162–70.

Article  PubMed  Google Scholar 

Sohail A, Sherin L, Butt SI, Javed S, Li Z, Iqbal S, et al. Role of key players in paradigm shifts of prostate cancer bone metastasis. Cancer Manag Res. 2018;10:1619–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giusti K, Hamermesh RG, Krasnow M. Addressing Demographic Disparities in Clinical Trials. Harvard Business Review. 2021.

Sharrocks K, Spicer J, Camidge DR, Papa S. The impact of socioeconomic status on access to cancer clinical trials. Br J Cancer. 2014;111:1684–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abraham-Miranda J, Awasthi S, Yamoah K. Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021;164:103426.

Article  PubMed  Google Scholar 

Esdaille AR, Ibilibor C, Holmes A 2nd, Palmer NR, Murphy AB. Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer. Urology. 2022;163:90–8.

Article  PubMed  Google Scholar 

Chinniah S, Stish B, Costello BA, Pagliaro L, Childs D, Quevedo F, et al. Radiation Therapy in Oligometastatic Prostate Cancer. Int J Radiat Oncol Biol Phys. 2022;114:684–92.

Vaishampayan UN, Heilbrun LK, Monk P 3rd, Tejwani S, Sonpavde G, Hwang C, et al. Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2021;4:e2034633.

Article  PubMed  PubMed Central  Google Scholar 

DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, et al. Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66:290–308.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

Article  PubMed  Google Scholar 

Chornokur G, Dalton K, Borysova ME, Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011;71:985–97.

Article  PubMed  Google Scholar 

Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer .2006;106:1276–85.

Article  PubMed  Google Scholar 

Nair SS, Chakravarty D, Dovey ZS, Zhang X, Tewari AK. Why do African-American men face higher risks for lethal prostate cancer? Curr Opin Urol. 2022;32:96–101.

Article  PubMed  Google Scholar 

Rebbeck TR, Haas GP. Temporal trends and racial disparities in global prostate cancer prevalence. Can J Urol. 2014;21:7496–506.

PubMed  PubMed Central  Google Scholar 

Powell IJ, Vigneau FD, Bock CH, Ruterbusch J, Heilbrun LK. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Cancer Epidemiol Biomark Prev. 2014;23:1505–11.

Article  Google Scholar 

Taitt HE. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location. Am J Mens Health. 2018;12:1807–23.

Article  PubMed  PubMed Central  Google Scholar 

Barsouk A, Padala SA, Vakiti A, Mohammed A, Saginala K, Thandra KC, et al. Epidemiology, Staging and Management of Prostate Cancer. Med Sci (Basel). 2020;8:28.

Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 1995;46:71–7.

Article  CAS  PubMed  Google Scholar 

Glover FE Jr., Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, et al. The epidemiology of prostate cancer in Jamaica. J Urol. 1998;159:1984–6.

Article  PubMed  Google Scholar 

Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: Int Comparisons BJU Int. 2002;90:162–73.

CAS  PubMed  Google Scholar 

Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T, Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London. BJU Int. 2006;98:1216–20.

Article  PubMed  Google Scholar 

Kelly SP, Rosenberg PS, Anderson WF, Andreotti G, Younes N, Cleary SD, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol. 2017;71:195–201.

Article  PubMed  Google Scholar 

Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124:315–32.

Article  PubMed  Google Scholar 

Deshmukh SK, Azim S, Ahmad A, Zubair H, Tyagi N, Srivastava SK, et al. Biological basis of cancer health disparities: resources and challenges for research. Am J Cancer Res. 2017;7:1–12.

PubMed  PubMed Central  Google Scholar 

Jia Z, Wang Y, Sawyers A, Yao H, Rahmatpanah F, Xia XQ, et al. Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Res. 2011;71:2476–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powell IJ, Bollig-Fischer A. Minireview: the molecular and genomic basis for prostate cancer health disparities. Mol Endocrinol. 2013;27:879–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gillard M, Javier R, Ji Y, Zheng SL, Xu J, Brendler CB, et al. Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men. Cancer Res. 2018;78:6134–45.

Article  CAS  PubMed  Google Scholar 

Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson RS 2nd, et al. Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res. 2011;71:1272–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, et al. Metastases in Prostate Cancer. Cold Spring Harb Perspect Med. 2019;9:a033688.

Kinseth MA, Jia Z, Rahmatpanah F, Sawyers A, Sutton M, Wang-Rodriguez J, et al. Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes. Int J Cancer. 2014;134:81–91.

Article  PubMed  Google Scholar 

Yuan J, Kensler KH, Hu Z, Zhang Y, Zhang T, Jiang J, et al. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry. PLoS Genet. 2020;16:e1008641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008;68:927–36.

Article  CAS  PubMed  Google Scholar 

Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, et al. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol. 2021;4:670.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lebrun JJ. The Dual Role of TGFbeta in Human Cancer: From Tumor Suppression to Cancer Metastasis. ISRN Mol Biol. 2012;2012:381428.

PubMed  PubMed Central  Google Scholar 

Elliott B, Zackery DL, Eaton VA, Jones RT, Abebe F, Ragin CC, et al. Ethnic differences in TGFbeta-signaling pathway may contribute to prostate cancer health disparity. Carcinogenesis. 2018;39:546–55.

Article  CAS  PubMed